Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

Topics
Activity report
Results
Acknowledgement

2025.08.25: Osaka-Kansai Expo "Science Exhibition: Connecting with Me and the Future" We exhibited at this event.
2025.07.25: Two PI Training Program recipients were selected for the FOREST (Fusion Oriented REsearch for disruptive Science and Technology) program.
PI Training Program recipients Dr. Yu Muta (Kyoto University) and Dr. Kimitoshi Kimura (Kyoto University) have been selected for the “5th FOREST Program”.
Following Dr. Atsushi Mitsuhashi (University of Tokushima) in the previous fiscal year, a total of three researchers from the PI Training Program (nine recipients ) have been selected for the FOREST Program (the selection rate for the 1st to 4th programs was approximately 10%, which is a very narrow selection gate).

About FOREST
In order to promote FOREST (Fusion Oriented REsearch for disruptive Science and Technology) program aiming to create seeds that lead to disruptive innovation through diversity and fusion without setting specific projects or short-term goals, this program provides long-term support for unrestricted, challenging and fusion-oriented diverse research not bound by the existing frameworks, for the period of seven years in principle (up to 10 years with an interim stage-gate review) while securing an environment in which researchers can devote themselves to their researches.
2025.03.06: The 5^th KENTO Co-Creation Forum was held.
2025.02.26: The 14^th Steering Committee meeting was held, and progress was shared with all members.
2025.02.19: As part of our support for startup creation/ growth promotion, we held the 5^th Startup Seminar
2025.02.17: As part of our support for startup creation/growth promotion, we held a Startup Seminar (special edition).
2025.02.13-16: We exhibited at the EXPO 2025 pre-event " Science : Connecting You to the Future."
2025.02.03,05: We held the final year report session for the Startup Creation/Growth Promotion Support Program.
2025.01.14: We held the PI Development Program Progress Report General Meeting.
2024.12.05: We held a joint symposium with the Tsukuba Digital-Bio International Center.

Osaka-Kansai Expo "Science Exhibition: Connecting with Me and the Future" We exhibited at this event.

Period | August 14, 2025 (Thursday) - August 19, 2025 (Tuesday)

Venue | Osaka-Kansai Expo Venue (Yumeshima) EXPO Messe "WASSE"

The National Cerebral and Cardiovascular Center participated in the interactive exhibition event “Science Connecting Me and the Future” (hosted by the Ministry of Education, Culture, Sports, Science and Technology) held at the Osaka-Kansai Expo site. Over the six-day event period, we shared the outcomes of our research project utilizing transparent fish (official name: Danionella cerebrum) with a total of 25,000 booth visitors.

This event aimed to create opportunities for the generation that will shape the future to personally engage with society's challenges, become protagonists in their own right, and contemplate “what kind of society they want to build for the future” by physically experiencing the future society envisioned by science. This exhibition provided visitors with the opportunity to directly observe actual transparent fish specimens. Furthermore, researchers conducted live demonstrations using.

Exhibition booth | Exhibiting transparent fish in an aquarium with a magnifying glass

Exhibition booth | Introduction of transparent fish on a large monitor and observation of transparent fish using a microscope

During the six-day event, the research results were disseminated to a total of 25,000 visitors

Report on the Startup Support Seminar [5th]

On Wednesday, February 19^th, we held the 5^th Startup Support Seminar. This time, we had a lecture by Daisuke Morishita of Chordia Therapeutics Inc., titled "The Reality of Listing a Drug Discovery Startup".
From his perspective as an experienced entrepreneur, he discussed the reality of listing a drug discovery startup, discussing the difficulties and issues unique to drug discovery startups.

We would like to thank all of you for attending.

Please look forward to future seminars.

◆ Report on the Startup Support Seminar [5th]
The Reality of Listing a Drug Discovery Startup
· Day and time : Wednesday February 19^th 18:00-19:30
· Venue : LINK-J WEST

· Speakers :: (Moderator)
Cabinet Office Bioeconomy Strategy Expert/LSIC Organizer, Lawyer
Nao Yoshizawa
(Speakers)
Chief Scientific Officer, Chordia Therapeutics Inc. Daisuke Morishita

Report on the Startup Support Seminar [Special Edition]

On Monday, February 17^th, we held the "Startup Support Seminar [Special Edition]". This time, the seminar was titled "Hybrid Seminar for the Application of AI in the life science sector," and speakers gave presentations on the current state and challenges of AI use, as well as implementation examples. We would like to thank the many people who participated both in person and online.

We hope you will join us in future seminars.

◆ JST COI-NEXT Program × Life Science Incubation Council [Special Edition]
Hybrid Seminar for the Application of AI in the life science sector
· Date and time : Monday, February 17^th 17:30-20:00
· Venue : Ochanomizu Sola City

· Speakers :: Soichiro Imaeda/Vice Minister of Education, Science & Technology
Mr. Nao Yoshizawa, Founder, Life Science Incubation Council
KPMG Consulting Co., Ltd., Mr. Seigo Hara
Cambridge Consultants Co., Ltd., Mr. Takuya Matsui
Oracle Japan, Mr. Yusuke Matsui
Juntendo University, Mr. Tamaki Nara
University College London, Institute of Ophthalmology and Moorfield’s Eye Hospital, Professor Pearse Keane
Professor of Drug Discovery Pharma & Bio Chemistry UCL School of Pharmacy, Professor Matthew Todd
Thermo Fisher Scientific, Dr. Natraj Ram

EXPO 2025 pre-event " Science : Connecting You to the Future. "

We exhibited at the Osaka Kansai EXPO Pre-Event "Connecting You to the Future, Science Exhibition" (Tokyo Innovation Base), held from February 13^th to 16^th. At our base, we exhibited Danionella cerebrum handled by the Kento Imaging Support Center and the National Cardiovascular Center Department of Cardiac Regeneration Biology, entitled "The New World of Microscopic Imaging: Danionella cerebrum".
Many people, including families and base personnel, stopped by to see the exhibit.
The actual event will be held from August 14th to 19th at the EXPO Messe (Yumeshima) in the Osaka Kansai EXPO site.

If you are visiting the Expo, please stop by!

2024.11.11: The following press release was issued by project leader Mochizuki Naoki and Yamagata University School of Medicine.
Zonated Wnt/β-catenin signal-activated cardiomyocytes at the atrioventricular canal promote coronary vessel formation in zebrafish
2024.09.19: There was a press release on the study of Dr. Takahisa Furukawa, the leader of R&D theme 5.
Ccrk-Mak/Ick signaling is a ciliary transport regulator essential for retinal photoreceptor survival
2024.09.17: Nobuhiro Nakai (Kobe University), a recipient of the PI Development Program, has been selected for the FY2024 “Advanced Research ＆ Development Programs for Medical (AMED-PRIME)”. (in Japanese only.)
2024.08.28: There was a press release on the study of Dr. Hiroshi Seno, the leader of R&D theme 2.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
2024.06.25: Atsushi Mitsuhashi (Tokushima University), a recipient of the PI Development Program, has been selected for the FY2023 “ Fusion oriented Research for disruptive Science and Technology (JST). (in Japanese only.)
2022.10.25: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070